Beyond The Numbers: 6 Analysts Discuss Merck & Co Stock
Beyond The Numbers: 6 Analysts Discuss Merck & Co Stock
數字之外：6位分析師討論默沙東股票
During the last three months, 6 analysts shared their evaluations of Merck & Co (NYSE:MRK), revealing diverse outlooks from bullish to bearish.
在過去的三個月中，6位分析師分享了他們對默沙東公司（紐約證券交易所代碼：MRK）的評估，揭示了從看漲到看跌的不同前景。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $146.17, a high estimate of $155.00, and a low estimate of $134.00. This current average reflects an increase of 0.34% from the previous average price target of $145.67.
分析師通過對12個月目標股價的評估提供了更深入的見解，顯示平均目標價爲146.17美元，最高估計爲155.00美元，低估值爲134.00美元。目前的平均價格比之前的平均目標價145.67美元上漲了0.34％。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：仔細觀察
The perception of Merck & Co by financial experts is analyzed...
通過分析師最近的行動分...
登入免費觀看全文
登入/註冊